Action Cardax (CE) - CDXI

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,000001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,0001

Clôture Veille

0,000001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

452

Volume financier

VWAP

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Collaboration Leverages Capsugel’s Proprietary Lipid-Based Technologies for Potential Development of Consumer Health Products Capsugel and...

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Cardax, Inc. (“Cardax”) (OTCQB:CDXI) announced today the appointment of George W. Bickerstaff, former CFO of Novartis Pharma AG (NYSE:NVS...

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Results Support Cardax Clinical Program Recent studies continue to support astaxanthin’s broad potential in chronic inflammatory disease...

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

Cardax, Inc. (“Cardax” or the “Company”) (OTCQB: CDXI) was featured recently in an in-depth article in the March 2014 issue of Hawaii...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	1.0E-6	1.0E-6	1.0E-6	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	0	0	CS
12	-9.0E-6	-90	1.0E-5	0.0001	1.0E-6	452	3.186E-5	CS
26	0	0	1.0E-6	0.0001	1.0E-6	343	4.015E-5	CS
52	0	0	1.0E-6	0.0001	1.0E-6	206	4.015E-5	CS
156	-0.799999	-99.999875	0.8	1	1.0E-6	538	0.2266818	CS
260	-6.249999	-99.999984	6.25	15	1.0E-6	1229	1.3851976	CS

CDXI - Frequently Asked Questions (FAQ)

What is the current Cardax (CE) share price?

The current share price of Cardax (CE) is US$ 0,000001

What is the 1 year trading range for Cardax (CE) share price?

Cardax (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
KTRIFKootenay Resources Inc (CE)	US$ 0,0368 (3 679 900,00%)	1,24k
VAXXVaxxinity Inc (CE)	US$ 0,05 (49 900,00%)	224
CCFLUCCF Holdings LLC (CE)	US$ 0,03527 (11 656,67%)	1,31k
FBCDFBC Holding Inc (PK)	US$ 0,0001 (9 900,00%)	510k
ALTDAltitude International Inc (CE)	US$ 0,0001 (9 900,00%)	467,28k
IPAHInterpharm Holdings Incorporated (CE)	US$ 0,000001 (-99,98%)	37,31k
STTOSITO Mobile Ltd (CE)	US$ 0,0002 (-99,88%)	278
PURAPuration Inc (CE)	US$ 0,000001 (-99,50%)	1,82M
PLPLPlandai Biotechnology Inc (PK)	US$ 0,000001 (-99,00%)	101k
NBRVFNabriva Therapeutics PLC (CE)	US$ 0,0001 (-99,00%)	261
GMPRGourmet Provisions International Corporation (PK)	US$ 0,0001 (9 900,00%)	287,63M
CATV4Cable TV International Inc (PK)	US$ 0,0007 (-12,50%)	224,6M
RONNRonn Motor Group Inc (PK)	US$ 0,0001 (-50,00%)	195,44M
HMBLHUMBL Inc (PK)	US$ 0,0004 (0,00%)	182,13M
DPLSDarkPulse Inc (PK)	US$ 0,0005 (-16,67%)	168,22M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cardax Inc (CE) (CDXI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

CDXI Dernières nouvelles

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

CDXI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cardax Inc (CE) (CDXI) Cours

Cardax Inc (CE) (CDXI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

CDXI Dernières nouvelles

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Cardax Appoints Former Novartis, Bristol-Myers Squibb, and Boehringer Ingelheim Executives as Directors

Recent Studies Further Demonstrate Astaxanthin’s Potential as a Safe and Effective Anti-Inflammatory

Hawaii Business Features Cardax in 'Hawaii-Born Pill: The Next Wonder Drug?'

CDXI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités